findmyKOL
Clinical trialNCT03598699CompletedPhase 2Interventional

A Study to Evaluate AXR-159 Ophthalmic Solution in Patients With Dry Eye Disease

SponsorAxeroVision, Inc.Enrollment102Dry Eye
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Protocol AXR201701 is a multicenter, double-masked, vehicle-controlled, randomized, parallel group study carried out in 2 stages (Stage 1: AXR-159 Ophthalmic Solution (30 mg/mL or 50 mg/mL); Stage 2: AXR-159 Ophthalmic Solution (3 mg/mL, 30 mg/mL or 50 mg/mL) in approximately 430 patients diagnosed with dry eye disease (DED).
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Eugene McLaurin, MD

    Total Eye Care, P.A., 6060 Primacy Parkway, Memphis, TN 38119

    Principal Investigator
    clinicaltrials.gov ↗
  • Gail L Torkildson, MD

    Andover Eye Associates, 138 Haverhill Street, Andover MA 01810

    Principal Investigator
    clinicaltrials.gov ↗
  • Kenneth R Kenyon, MD

    Andover Eye Associates, 675 Paramount Drive, Raynham, MA 02767

    Principal Investigator
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Andover Eye Associates

    Andover, Massachusetts, United States

  • Andover Eye Associates

    Raynham, Massachusetts, United States

  • Total Eye Care, P.A.

    Memphis, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

AXR-159Vehicle
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
26 Jun 2018
Primary completion
28 Dec 2018
Completion
9 Jan 2019
Last update posted
13 Oct 2023
Registered enrollment
102
Registry id
NCT03598699
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.